Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Women with keloid scars often have acne and hair loss, especially those with "true" keloids, indicating a possible hormonal imbalance.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.

Different levels of microRNAs in different parts of the scalp can cause male pattern baldness.

Testosterone increases muscle mass regardless of DHT conversion blocking.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

A mushroom extract might reduce hair loss and liver damage caused by certain chemotherapy drugs in animals.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.